Thanh bên bài viết
Ngày xuất bản:
20/05/2023
Ngày xuất bản Online:
20/05/2023
Số lượt xem tóm tắt: 250
Số lượt xem bài toàn văn.pdf: 134
Số lượt xem bài toàn văn.pdf: 134
Số xuất bản
Chuyên mục
Bài báo
Trích dẫn bài báo
Nguyễn, N. T. (2023). Tổng quan một phương pháp điều trị vết thương mới: Sử dụng cục máu đông tự thân toàn phần. Tạp chí Y học Thảm hoạ và Bỏng, 2, 58-68. https://doi.org/10.54804/yhthvb.2.2023.227
Tổng quan một phương pháp điều trị vết thương mới: Sử dụng cục máu đông tự thân toàn phần
Nội dung chính của bài viết
Tóm tắt
Vết thương mạn tính (VTMT) hoặc không liền được định nghĩa là vết thương (VT) tiến triển chậm qua các giai đoạn liền vết thương (LVT), hoặc bị gián đoạn hoặc chậm liền do các yếu tố bên trong và bên ngoài tác động lên VT hoặc yếu tố cá thể (Sibbald et al, 2015; Woo et al, 2015; Woo et al, 2018) [1-3]. Vết thương không liền có thể cho thấy sự hiện diện của màng sinh học. VTMT hay gặp bao gồm loét tiểu đường, loét mạch máu (loét tĩnh mạch và động mạch), loét do tỳ đè và khối u ác tính. Quản lý, chăm sóc theo dõi và điều trị VTMT và các bệnh lý tiềm ẩn là điều cần thiết.
Chi tiết bài viết
Tài liệu tham khảo
1. Fridman and Dino RechSibbald RG, Elliott JA, Ayello EA, Somayaji R (2015); Optimizing the moisture management tightrope with wound bed preparation. Adv Skin Wound Care;28(10): 466-76.
2. Woo KY, Krasner DL, Kennedy B et al (2015); Palliative wound care management strategies for palliative patients and their circles of care. Adv Skin Wound Care 28(3): 130-40, quiz 140-2
3. Woo K, de Gouveia Santos VLC, Alam T (2018); Optimising quality of life for people with non-healing wounds. Wounds International 9(3): 6-14
4. Aitken SJ, Choy OS, Monaro S (2019), A qualitative study exploring patient concerns and values in chronic limb-threatening ischemia. J Surg Res 243: 289-300
5. Zhao R, Liang H, Clarke E, et al (2016); Inflammation in chronic wounds. Int J Mol Sci 17(12): 2085
6. Sibbald RG, Goodman L, Woo KY, et al (2011), Special considerations in wound bed preparation 2011: an update. Adv Skin Wound Care 24(9): 415-36; quiz 437-8
7. Han G, Ceilley R (2017) Chronic wound healing: a review of current management and treatments. Adv Ther 34(3): 599-610
8. Boersema GC, Smart H, Giaquinto-Cilliers MG, et al (2021); Management of unhealable and maintenance wounds: a systematic integrative review and referral pathway. Adv Skin Wound Care 34(1): 11-22
9. Young A, McNaught C-E (2011) The physiology of wound healing. Surgery (Oxford) 29(10): 475-79
10. Han G, Ceilley R (2017) Chronic wound healing: a review of current management and treatments. Adv Ther 34(3): 599-610
11. Conde-Montero E, de la Cueva Dobao P, Martínez González JM (2017) Platelet-rich plasma for the treatment of chronic wounds: evidence to date Chronic Wound Care Management and Research » Volume 4, p.107-120
12. Haugh AM, Witt JG, Hauch A, et al (2017) Amnion membrane in diabetic foot wounds: a meta-analysis. Plast Reconstr Surg Glob Open 5(4): e1302
13. Dehghani M, Azarpira N, Karimi VM, et al (2017) Grafting with cryopreserved amniotic membrane versus conservative wound care in treatment of pressure ulcers: a randomized clinical trial. Bull Emerg Trauma 5(4): 249-58.
14. Serena TE, Kushnir I, Kushnir A, et al (2019) The safety of an autologous whole blood clot product applied to full-thickness dermal wounds in a porcine model for up to 18 days. Chronic Wound Care Management and Research 6: 39-49.
15. Su YN, Zhao DY, Li YH et al (2020) Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: A systematic review and meta‐analysis of randomised controlled trials. Int Wound J 17(3): 753-64.
16. Kranke P, Bennett MH, Martyn Saint-James, et al (2015) Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015(6): CD004123.
17. Santema KT, Stoekenbroek RM, Koelemay MJ, et al (2018) Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2LES multicenter randomized clinical trial. diabetes care 41(1): 112-9.
18. Lee Y, Phillips SA, Stacey MC (2018) The use of growth factors for the treatment of chronic venous leg ulcers: a systematic review and meta-analysis. J Vasc Surg 68(3): e88-e89.
19. Carvalho MRD, Silveira IA, de Oliveira BGBR (2019) Treatment of venous ulcers with growth factors: systematic review and meta-analysis. Rev Bras Enferm 72(1): 200-10.
20. Martī-Carvajal AJ, Gluud C, Nicola S, et al (2015) Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev (10): CD008548.
21. Lalezari S, Lee CJ, Borovikova AA, et al (2017) Deconstructing negative pressure wound therapy. Int Wound J 14(4): 649-57.
22. Andonegi M, Las Heras K, Santos-Vizcaino E, et al (2020) Structure-properties relationship of chitosan/collagen films with potential for biomedical applications. Carbohydr Polym 237: 116159.
23. Olaiya OR, Huynh M, McRae MH (2020) Comment on: “Negative pressure wound therapy reduces wound breakdown and implant loss in pre pectoral breast reconstruction. Plast Reconstr Surg Glob Open 8(6): e2908.
24. Wahab N, Lapucha M, Chauhan C, Abellera J (2020) Initial experience using autologous blood clot to promote closure in chronic pressure ulceration. Poster Presentation: Symposium on Advanced Wound Care, 2020. Available at: https://bit.ly/3uF3RFY (accessed 11.05.2021).
25. Kitchens BP, Synder RJ, Cuffy CA (2020) A literature review of pharmacological agents to improve venous leg ulcer healing. Wounds 32(7): 195-207.
26. Liezl Naude, Patricia Idensohn, Febe Bruwer et all 2021. An observational pilot study to collect safety and efficacy data on wound care using whole blood clot technology on hard-to-heal wounds; Wounds International 2021 Vol 12 Issue 2.
27. Kushnir I, Kushnir A, Garfinkel D, Serena TE (2016) Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study. Wounds Research 28(9): 317-327.
28. Snyder RJ, Schultz G, Wachuku C, Rashid AM, Ead JK (2020) Proposed Mechanism of Action of Topically Applied Autologous Blood Clot Tissue: A Quintessential Cellular and Tissue-Based Therapy. J Am Podiatr Med Assoc pp. 20-140.
29. Kwon SH, Padmanabhan J, Henn D, Chen K, Gurtner GC (2020) New won SH, Padmanabhan J, Henn D, Chen K, Gurtner GC (2020) New Drugs for Scar Treatment. Textbook on Scar Management pp. 457-463.
30. Richard D Curtis, and Chinenye D Wachuku; 2021 Utilization of ActiGraft, an Autologous (Blood Clot) Graft in the Reconstruction of Soft Tissue Deficit from Hand Trauma - A Case Study; Annals of Reviews and Research; Volume 6 Issue 4 - May 2021,001-006.
31. Robert J. Snyder, Maria A. Kasper, Keyur Patel, Marissa J. Carter, Igal Kushnir, Alon Kushnir, and Thomas E. Serena 2018; Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open-Label Pilot Study; Wounds 2018;30(7):205-212. Epub 2018 April 20.
32. Maxim Gurevich, Stephen M Heinz, Ruhama Fridman, Jessie Hawkins, Chinenye D Wachuku. Use of autologous whole blood clot in the treatment of complex surgical wounds: a case series; February 2023; Journal of Wound Care 32(Sup2): S4-S9.
33. L Naude; G Balenda; A Lombaard; Autologous whole blood clot and negative-pressure wound therapy in South Africa: A comparison of the cost and social considerations; S Afr Med J 2022;112(10):800-805
2. Woo KY, Krasner DL, Kennedy B et al (2015); Palliative wound care management strategies for palliative patients and their circles of care. Adv Skin Wound Care 28(3): 130-40, quiz 140-2
3. Woo K, de Gouveia Santos VLC, Alam T (2018); Optimising quality of life for people with non-healing wounds. Wounds International 9(3): 6-14
4. Aitken SJ, Choy OS, Monaro S (2019), A qualitative study exploring patient concerns and values in chronic limb-threatening ischemia. J Surg Res 243: 289-300
5. Zhao R, Liang H, Clarke E, et al (2016); Inflammation in chronic wounds. Int J Mol Sci 17(12): 2085
6. Sibbald RG, Goodman L, Woo KY, et al (2011), Special considerations in wound bed preparation 2011: an update. Adv Skin Wound Care 24(9): 415-36; quiz 437-8
7. Han G, Ceilley R (2017) Chronic wound healing: a review of current management and treatments. Adv Ther 34(3): 599-610
8. Boersema GC, Smart H, Giaquinto-Cilliers MG, et al (2021); Management of unhealable and maintenance wounds: a systematic integrative review and referral pathway. Adv Skin Wound Care 34(1): 11-22
9. Young A, McNaught C-E (2011) The physiology of wound healing. Surgery (Oxford) 29(10): 475-79
10. Han G, Ceilley R (2017) Chronic wound healing: a review of current management and treatments. Adv Ther 34(3): 599-610
11. Conde-Montero E, de la Cueva Dobao P, Martínez González JM (2017) Platelet-rich plasma for the treatment of chronic wounds: evidence to date Chronic Wound Care Management and Research » Volume 4, p.107-120
12. Haugh AM, Witt JG, Hauch A, et al (2017) Amnion membrane in diabetic foot wounds: a meta-analysis. Plast Reconstr Surg Glob Open 5(4): e1302
13. Dehghani M, Azarpira N, Karimi VM, et al (2017) Grafting with cryopreserved amniotic membrane versus conservative wound care in treatment of pressure ulcers: a randomized clinical trial. Bull Emerg Trauma 5(4): 249-58.
14. Serena TE, Kushnir I, Kushnir A, et al (2019) The safety of an autologous whole blood clot product applied to full-thickness dermal wounds in a porcine model for up to 18 days. Chronic Wound Care Management and Research 6: 39-49.
15. Su YN, Zhao DY, Li YH et al (2020) Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: A systematic review and meta‐analysis of randomised controlled trials. Int Wound J 17(3): 753-64.
16. Kranke P, Bennett MH, Martyn Saint-James, et al (2015) Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015(6): CD004123.
17. Santema KT, Stoekenbroek RM, Koelemay MJ, et al (2018) Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2LES multicenter randomized clinical trial. diabetes care 41(1): 112-9.
18. Lee Y, Phillips SA, Stacey MC (2018) The use of growth factors for the treatment of chronic venous leg ulcers: a systematic review and meta-analysis. J Vasc Surg 68(3): e88-e89.
19. Carvalho MRD, Silveira IA, de Oliveira BGBR (2019) Treatment of venous ulcers with growth factors: systematic review and meta-analysis. Rev Bras Enferm 72(1): 200-10.
20. Martī-Carvajal AJ, Gluud C, Nicola S, et al (2015) Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev (10): CD008548.
21. Lalezari S, Lee CJ, Borovikova AA, et al (2017) Deconstructing negative pressure wound therapy. Int Wound J 14(4): 649-57.
22. Andonegi M, Las Heras K, Santos-Vizcaino E, et al (2020) Structure-properties relationship of chitosan/collagen films with potential for biomedical applications. Carbohydr Polym 237: 116159.
23. Olaiya OR, Huynh M, McRae MH (2020) Comment on: “Negative pressure wound therapy reduces wound breakdown and implant loss in pre pectoral breast reconstruction. Plast Reconstr Surg Glob Open 8(6): e2908.
24. Wahab N, Lapucha M, Chauhan C, Abellera J (2020) Initial experience using autologous blood clot to promote closure in chronic pressure ulceration. Poster Presentation: Symposium on Advanced Wound Care, 2020. Available at: https://bit.ly/3uF3RFY (accessed 11.05.2021).
25. Kitchens BP, Synder RJ, Cuffy CA (2020) A literature review of pharmacological agents to improve venous leg ulcer healing. Wounds 32(7): 195-207.
26. Liezl Naude, Patricia Idensohn, Febe Bruwer et all 2021. An observational pilot study to collect safety and efficacy data on wound care using whole blood clot technology on hard-to-heal wounds; Wounds International 2021 Vol 12 Issue 2.
27. Kushnir I, Kushnir A, Garfinkel D, Serena TE (2016) Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study. Wounds Research 28(9): 317-327.
28. Snyder RJ, Schultz G, Wachuku C, Rashid AM, Ead JK (2020) Proposed Mechanism of Action of Topically Applied Autologous Blood Clot Tissue: A Quintessential Cellular and Tissue-Based Therapy. J Am Podiatr Med Assoc pp. 20-140.
29. Kwon SH, Padmanabhan J, Henn D, Chen K, Gurtner GC (2020) New won SH, Padmanabhan J, Henn D, Chen K, Gurtner GC (2020) New Drugs for Scar Treatment. Textbook on Scar Management pp. 457-463.
30. Richard D Curtis, and Chinenye D Wachuku; 2021 Utilization of ActiGraft, an Autologous (Blood Clot) Graft in the Reconstruction of Soft Tissue Deficit from Hand Trauma - A Case Study; Annals of Reviews and Research; Volume 6 Issue 4 - May 2021,001-006.
31. Robert J. Snyder, Maria A. Kasper, Keyur Patel, Marissa J. Carter, Igal Kushnir, Alon Kushnir, and Thomas E. Serena 2018; Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open-Label Pilot Study; Wounds 2018;30(7):205-212. Epub 2018 April 20.
32. Maxim Gurevich, Stephen M Heinz, Ruhama Fridman, Jessie Hawkins, Chinenye D Wachuku. Use of autologous whole blood clot in the treatment of complex surgical wounds: a case series; February 2023; Journal of Wound Care 32(Sup2): S4-S9.
33. L Naude; G Balenda; A Lombaard; Autologous whole blood clot and negative-pressure wound therapy in South Africa: A comparison of the cost and social considerations; S Afr Med J 2022;112(10):800-805